Milestone Scientific (MLSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -615 | -1,530 | -1,188 | -3,152 | -2,754 |
| Depreciation Amortization | 131 | 180 | 155 | 119 | 118 |
| Accounts receivable | -734 | -138 | -579 | 11 | 41 |
| Accounts payable and accrued liabilities | 2,170 | 325 | -892 | 688 | 34 |
| Other Working Capital | -638 | 226 | 156 | 846 | -1,363 |
| Other Operating Activity | -608 | 1,340 | 1,906 | -163 | 658 |
| Operating Cash Flow | $-294 | $403 | $-442 | $-1,651 | $-3,266 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29 | -22 | -5 | -19 | -23 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -6 |
| Purchase Sale Intangibles | -81 | -122 | -304 | -63 | -306 |
| Other Investing Activity | -79 | -122 | -304 | -63 | -306 |
| Investing Cash Flow | $-108 | $-144 | $-309 | $-82 | $-336 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 750 | N/A | N/A |
| Common Stock Issued | N/A | 27 | N/A | N/A | 1 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 3,453 |
| Financing Cash Flow | $N/A | $27 | $750 | $N/A | $3,454 |
| Beginning Cash Position | 1,029 | 744 | 745 | 2,893 | 3,041 |
| End Cash Position | 627 | 1,029 | 744 | 1,160 | 2,893 |
| Net Cash Flow | $-402 | $286 | $-1 | $-1,733 | $-149 |
| Free Cash Flow | |||||
| Operating Cash Flow | -294 | 403 | -442 | -1,651 | -3,266 |
| Capital Expenditure | -29 | -52 | -13 | -19 | -23 |
| Free Cash Flow | -323 | 351 | -455 | -1,670 | -3,289 |